A Phase 1 Study to Evaluate the Pharmacokinetic Interaction Potential Between BIIB074 and an Oral Contraceptive Regimen in Healthy Female Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Vixotrigine (Primary) ; Estradiol/levonorgestrel
- Indications Erythromelalgia; Neuropathic pain; Trigeminal neuralgia
- Focus Pharmacokinetics
- Sponsors Biogen
- 27 Feb 2018 Planned End Date changed from 16 Mar 2018 to 3 Apr 2018.
- 27 Feb 2018 Planned primary completion date changed from 15 Feb 2018 to 5 Mar 2018.
- 01 Nov 2017 New trial record